Trial · NCT00593736
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Screening Period and Placebo Run-in | STARTED | Ramelteon 1 mg QD | 0 | |
| Screening Period and Placebo Run-in | STARTED | Ramelteon 4 mg QD | 0 | |
| Screening Period and Placebo Run-in | STARTED | Ramelteon 8 mg QD | 0 | |
| Screening Period and Placebo Run-in | STARTED | Placebo QD | 549 | |
| Screening Period and Placebo Run-in | COMPLETED | Ramelteon 1 mg QD | 0 | |
| Screening Period and Placebo Run-in | COMPLETED | Ramelteon 4 mg QD | 0 | |
| Screening Period and Placebo Run-in | COMPLETED | Ramelteon 8 mg QD | 0 | |
| Screening Period and Placebo Run-in | COMPLETED | Placebo QD | 132 | |
| Screening Period and Placebo Run-in | NOT COMPLETED | Ramelteon 1 mg QD | 0 | |
| Screening Period and Placebo Run-in | NOT COMPLETED | Ramelteon 4 mg QD | 0 | |
| Screening Period and Placebo Run-in | NOT COMPLETED | Ramelteon 8 mg QD | 0 | |
| Screening Period and Placebo Run-in | NOT COMPLETED | Placebo QD | 417 | |
| Treatment Period and Placebo Run-out | STARTED | Ramelteon 1 mg QD | 32 | |
| Treatment Period and Placebo Run-out | STARTED | Ramelteon 4 mg QD | 33 | |
| Treatment Period and Placebo Run-out | STARTED | Ramelteon 8 mg QD | 35 | |
| Treatment Period and Placebo Run-out | STARTED | Placebo QD | 32 | |
| Treatment Period and Placebo Run-out | COMPLETED | Ramelteon 1 mg QD | 29 | |
| Treatment Period and Placebo Run-out | COMPLETED | Ramelteon 4 mg QD | 31 | |
| Treatment Period and Placebo Run-out | COMPLETED | Ramelteon 8 mg QD | 30 | |
| Treatment Period and Placebo Run-out | COMPLETED | Placebo QD | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00593736/flow